Coherus BioSciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023
Coherus BioSciences, Inc. (CHRS) announced that it will release its fourth quarter and full year 2022 financial results on March 6, 2023, after market close. The company will host a conference call and webcast at 5:00 pm ET that same day to discuss the results and provide a business update. Interested parties can access the conference call by pre-registering for dial-in information. A replay of the webcast and press release will be available on Coherus' investor website after the call.
- Anticipated release of fourth quarter and full year 2022 financial results
- Conference call to provide a business update and engage with investors
- None.
REDWOOD CITY, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus“, Nasdaq: CHRS) today announced that its fourth quarter and full year 2022 financial results will be released after market close on Monday, March 6, 2023. Starting at 5:00 pm ET on March 6, 2023, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update.
A replay of the webcast will be available on http://investors.coherus.com following the conclusion of the live conference call.
Conference Call Information
When: Monday, March 6th, 2023, starting at 5:00 p.m. Eastern Time
To access the conference call, please pre-register through the following link to receive dial-in information and a personal PIN to access the live call: https://register.vevent.com/register/BI8a3cc318d81c4ebaa9d8f6e635f9731c
Webcast: https://edge.media-server.com/mmc/p/jcpis3ko
The press release with the fourth quarter and full year 2022 financial results and related materials will be available at https://investors.coherus.com prior to the start of the conference call.
A live and archived webcast will be available on the “Investors” section of the Coherus website at http://investors.coherus.com.
Please dial-in 15 minutes early to ensure a timely connection to the call.
Coherus Contact Information:
Marek Ciszewski, SVP Investor Relations
IR@coherus.com
FAQ
When will Coherus BioSciences release its fourth quarter and full year 2022 financial results?
What time is the conference call for Coherus BioSciences' financial results?
How can I access the conference call for Coherus BioSciences?